56 related articles for article (PubMed ID: 15164374)
1. Use of alveolar carbon monoxide to measure the effect of ribavirin on red blood cell survival.
Virtue MA; Furne JK; Ho SB; Levitt MD
Am J Hematol; 2004 Jun; 76(2):107-13. PubMed ID: 15164374
[TBL] [Abstract][Full Text] [Related]
2. Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival.
Furne JK; Springfield JR; Ho SB; Levitt MD
J Lab Clin Med; 2003 Jul; 142(1):52-7. PubMed ID: 12878986
[TBL] [Abstract][Full Text] [Related]
3. Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases.
Mitlyng BL; Singh JA; Furne JK; Ruddy J; Levitt MD
Am J Hematol; 2006 Jun; 81(6):432-8. PubMed ID: 16680757
[TBL] [Abstract][Full Text] [Related]
4. Use of breath carbon monoxide to measure the influence of prosthetic heart valves on erythrocyte survival.
Mitlyng BL; Chandrashekhar Y; Furne JK; Levitt MD
Am J Cardiol; 2006 May; 97(9):1374-6. PubMed ID: 16635614
[TBL] [Abstract][Full Text] [Related]
5. Estimation of red blood cell lifespan from alveolar carbon monoxide measurements.
Krishnan SM; Dixit NM
Transl Res; 2009 Jul; 154(1):15-7. PubMed ID: 19524869
[TBL] [Abstract][Full Text] [Related]
6. A simple carbon monoxide breath test to estimate erythrocyte turnover.
Strocchi A; Schwartz S; Ellefson M; Engel RR; Medina A; Levitt MD
J Lab Clin Med; 1992 Sep; 120(3):392-9. PubMed ID: 1517686
[TBL] [Abstract][Full Text] [Related]
7. Rapid CO breath test screening of drugs for protective effects on ribavirin-induced hemolysis in a rabbit model: a pilot study.
Ma YJ; Zhang HD; Wu CH; Zhu GL; Ji YQ; Huang JL; Du LT; Cao P; Zang DY; Ji KM
J Breath Res; 2016 Aug; 10(3):036010. PubMed ID: 27506143
[TBL] [Abstract][Full Text] [Related]
8. High dose of erythropoietin in management of interferon/ribavirin induced anemia.
Ucciferri C; Falasca K; Mancino P; De Tullio D; Pizzigallo E; Vecchiet J
Hepatogastroenterology; 2007 Dec; 54(80):2181-3. PubMed ID: 18265628
[TBL] [Abstract][Full Text] [Related]
9. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hepatitis C virus infection in thalassemia.
Butensky E; Pakbaz Z; Foote D; Walters MC; Vichinsky EP; Harmatz P
Ann N Y Acad Sci; 2005; 1054():290-9. PubMed ID: 16339677
[TBL] [Abstract][Full Text] [Related]
11. Diurnal rhythm of heme turnover assessed by breath carbon monoxide concentration measurements.
Levitt MD; Ellis C; Levitt DG
J Lab Clin Med; 1994 Sep; 124(3):427-31. PubMed ID: 8083586
[TBL] [Abstract][Full Text] [Related]
12. Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia.
Grattagliano I; Russmann S; Palmieri VO; Portincasa P; Palasciano G; Lauterburg BH
Clin Pharmacol Ther; 2005 Oct; 78(4):422-32. PubMed ID: 16198661
[TBL] [Abstract][Full Text] [Related]
13. Ifn/Rbv treatment induced anemia and its correction with epoetin alpha in patients with hepatitis C.
Sharvadze L; Tsertsvadze T; Gochitashvili N; Kakabadze T; Dolmazashvili E
Georgian Med News; 2006 Aug; (137):62-5. PubMed ID: 16980747
[TBL] [Abstract][Full Text] [Related]
14. Blood ribavirin concentration in high-dose ribavirin for adenovirus-induced haemorrhagic cystitis - a case report.
Homma M; Inoue Y; Hasegawa Y; Kojima H; Kohda Y
J Clin Pharm Ther; 2008 Feb; 33(1):75-8. PubMed ID: 18211620
[TBL] [Abstract][Full Text] [Related]
15. Measurement of ribavirin plasma concentrations by high-performance liquid chromatography using a novel solid-phase extraction method in patients treated for chronic hepatitis C.
Morello J; Rodríguez-Nóvoa S; Cantillano AL; González-Pardo G; Jiménez I; Soriano V
Ther Drug Monit; 2007 Dec; 29(6):802-6. PubMed ID: 18043479
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.
Aweeka FT; Kang M; Yu JY; Lizak P; Alston B; Chung RT;
HIV Med; 2007 Jul; 8(5):288-94. PubMed ID: 17561874
[TBL] [Abstract][Full Text] [Related]
17. Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence.
Sharma P; Marrero JA; Fontana RJ; Greenson JK; Conjeevaram H; Su GL; Askari F; Sullivan P; Lok AS
Liver Transpl; 2007 Aug; 13(8):1100-8. PubMed ID: 17377914
[TBL] [Abstract][Full Text] [Related]
18. Changes in serum and red blood cell membrane lipids in patients treated with interferon ribavirin for chronic hepatitis C.
Tanaka H; Miyano M; Ueda H; Fukui K; Ichinose M
Clin Exp Med; 2005 Dec; 5(4):190-5. PubMed ID: 16362799
[TBL] [Abstract][Full Text] [Related]
19. Focus on hepatitis. Increased RBV dose for better HCV treatment response.
Bernard EJ
IAPAC Mon; 2006 Jan; 12(1):18. PubMed ID: 17249131
[No Abstract] [Full Text] [Related]
20. Analysis of red cell parameters on the Sysmex XE 2100 and ADVIA 120 in iron deficiency and in uraemic chronic disease.
David O; Grillo A; Ceoloni B; Cavallo F; Podda G; Biancotti PP; Bergamo D; Canavese C
Scand J Clin Lab Invest; 2006; 66(2):113-20. PubMed ID: 16537244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
